Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors (Q40774621)

23 September 2017

Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors (English)

1 reference

23 September 2017

0 references

0 references

3

1 reference

23 September 2017

L De Petrocellis

1

1 reference

PubMed ID

11602256

23 September 2017

J B Davis

series ordinal

2

1 reference

PubMed ID

11602256

23 September 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

23 September 2017

1 reference

23 September 2017

506

1 reference

23 September 2017

253-256

1 reference

23 September 2017

3

1 reference

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

N-acylated glycerophospholipids and their derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Control of pain initiation by endogenous cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

The fatty acid amide hydrolase (FAAH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

The capsaicin receptor: a heat-activated ion channel in the pain pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Induction of vanilloid receptor channel activity by protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Anandamide: some like it hot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Cloning and functional expression of a human orthologue of rat vanilloid receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902934-9

10.1016/S0014-5793(01)02934-9

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

11602256